ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 22709 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 22709; 2) Community: the network communities that were significantly associated with the response to NSC 22709; 3) Molecule: the relationships between components within communities and NSC 22709; 4) MDR: the compounds that were significantly associated with the NSC 22709.

NSC Compound Enrichment Correlation
NSC 709518 Null 0.0297837393005856 0.34284818
NSC 716122 Null 0.0297837393005856 0.10499966
NSC 716715 Null 0.0297837393005856 0.13423122
NSC 718165 Null 0.0297837393005856 0.27219561
NSC 727086 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-3a-pyrrolidino-5-androsten-17a-yl acetate 0.0297837393005856 0.26575494
NSC 742554 7H-Furo[3,2-g][1]benzopyran-7-one, 4-[[(2E)-5-[4'-[[(2E)-6,7-dihydroxy-3,7-dimethyl-2-octenyl]oxy]-5,5-dimethyl-spiro[1,3-dioxolane-2,7'-[7H]furo[3,2-g][1]benzopyran]-4-yl]-3-methyl-2-pentenyl]oxy]-, 0.0297837393005856 0.26814816
NSC 748643 Mitaplatin 0.0297837393005856 0.28299333
NSC 752503 2,7-Bis-[2-(3,4,5-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone dipara-toluensulfonate dihydrate salt 0.0297837393005856 0.23031452
NSC 756413 GW876790X 0.0297837393005856 -0.18231571
NSC 756420 SB-223133 0.0297837393005856 -0.27918033
Total:105  Current:73    [First] [Prev] [Next] [Last]